Arizona Tribune - BioLargo Invited to Showcase PFAS Treatment Technology at Industry Leading Water Conference

WESTMINSTER, CA / ACCESS Newswire / March 10, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that it will present data demonstrating industry-leading PFAS removal and destruction from landfill leachate (the contaminant-laden water that drains from landfills) at the Air & Waste Management Association's (A&WMA) "The Science of PFAS" conference on March 12, 2025 (https://www.awma.org/pfas).

Founded over 100 years ago, the A&WMA is the United States' oldest environmental organization, dedicated to advancing knowledge and expertise in environmental management for more than 5,000 environmental professionals across 65 countries. A&WMA's "The Science of PFAS" conference will "bring together scientists, researchers, academics, practitioners, regulators, and the regulated community to further the conversation on the current state of PFAS science and solutions for the future."

Tonya Chandler, President of BioLargo Equipment Solutions & Technologies, Inc., will showcase new and important results from BioLargo's Aqueous Electrostatic Concentrator (AEC), a technology that selectively captures PFAS, enabling effective and cost-efficient PFAS collection from water, wastewater, and landfill leachate without generating significant waste by-products. BioLargo's treatment solution can remove and destroy all PFAS (short, medium, and long-chain) to industry-unmatched "non-detect" levels (less than 1 part per trillion), leaving behind only inert salts. Newly completed trials demonstrate the AEC's ability to treat landfill leachate contaminated with PFAS, one of the most challenging and important waste streams for prevention of the release of dangerous PFAS chemicals into the environment.

Chandler commented, "We're honored to be invited to present alongside a distinguished group of leaders in environmental stewardship and implementation of advanced water and air technologies at A&WMA's The Science of PFAS conference, including representatives from the U.S. Environmental Protection Agency and other federal agencies. Our leachate PFAS treatment results are sure to leave a strong impression with this audience."

About Per- and Polyfluoroalkyl Substances

PFAS are synthetic chemicals commonly found in household items such as electronics, cleaning products, and non-stick cookware. While the presence of PFAS in these products is not necessarily hazardous, their extensive production during the latter half of the 20th century has resulted in widespread contamination of lakes, rivers, wells, and groundwater across the United States. In recent decades, growing evidence has linked these chemicals to serious health risks, including cancer and hormone disorders. Removing PFAS from water is challenging because the chemicals are resistant to treatment methods that can capture or break down other common organic water contaminants, creating a need for new water treatment techniques to specifically target PFAS.

About BioLargo, Inc.

BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

SOURCE: BioLargo, Inc.

View the original press release on ACCESS Newswire

H.Gonzales--AT